Navigation Links
Novel aspects of histamine research discussed in Versita open access book
Date:11/13/2013

Histamine H4 Receptors: A novel Drug Target for Immunomodulation and Inflammation, edited by Professor Holger Stark, is a new Open Access Book comprising key results from the highly acclaimed Action BM0806, held by COST (European Cooperation in Science and Technology), which was instituted to champion and promote a multidisciplinary approach to H4R research, and focused on the current state of play pertaining to the basic understanding and the huge therapeutic potential of this new drug target. The objective of this project was to advance awareness of the newly identified histamine receptor.

The book describes molecular signaling mechanism, the function as well as the localization of this receptor subtype, along with its influence on physiological and pathophysiological properties. It offers an insight into a range of perspectives on H4R research, and a thorough analysis of the possibilities for novel therapeutic inventions and exploitation, allowing for newly designed compounds as well as numerous biochemical in vitro and in vivo models on different species.

Chapter by chapter, different aspects of histamine research are presented and discussed. The contributing authors were all active members of Action BM0806 and as a result, the book covers the most original and topical aspects of histamine research. One of them is the role of histamine in allergic reactions, which was assumed to have been clarified for many decades. Presently, the increased understanding of histamine and its functions places it at the centre stage in the orchestration of the innate immune response and lead-up to the adaptive response. Professor Madeleine Ennis (Secretary, COST Action BM0806) and colleagues discuss in detail the evidence for the roles of various histamine receptors (particularly the H4R) in immune cell function, spanning eosinophils, monocytes, basophils, mast cells and neutrophils. Another newsworthy section, dedicated to histamine and cancer, is written by one of the leading specialists in the field Professor Elena S. Rivera, a global expert on histamine and cell proliferation, who provides exciting new data that supports the H4R as a novel target for a range of refractory cancers. Finally, the closing chapter discusses the non-receptor role of histamine a fascinating topic, albeit so far largely under-studied by the histamine community.

Considering its cross-sectional approach, the book will benefit not only societies and professional organizations, but all scientists involved in biogenic amine research and those with special emphasis on histamine research should find it an invaluable read. As Dr. Paul L Chazot, President of European Histamine Research Society points out: "This new Book offers something for everyone across disciplines, and individuals with either a deep or passing interest in histamine will be kept entertained and informed."


'/>"/>

Contact: Maria Hrynkiewicz
maria@versita.com
48-660-476-421
Versita
Source:Eurekalert  

Related biology news :

1. Novel LEDs pave the way to cheaper displays
2. Novel technique for suturing tissue-engineered collagen graft improves tendon repair
3. Novel mutations define 2 types of bone tumor
4. NIH funds development of novel robots to assist people with disabilities, aid doctors
5. Mutations in novel tumor suppressor gene associated with early onset breast cancer
6. IRICoR and Université de Montréal license a novel program for early-onset morbid obesity to Pfizer
7. Novelty of eco-friendly bamboo garments lures consumers -- if the price is right, Baylor study shows
8. Novel mechanism discovered in first line of immune defense
9. Novel avian influenza A virus has potential for both virulence and transmissibility in humans
10. Researchers develop novel polymer to help oral medications reach the bloodstream
11. Novel approach to gene regulation can activate multiple genes simultaneously
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Novel aspects of histamine research discussed in Versita open access book
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016  Blueprint Bio, a company dedicated to identifying, ... community, has closed its Series A funding round, according ... "We have received a commitment from Forentis Fund ... to meet our current goals," stated Matthew Nunez ... to complete validation on the current projects in our ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® ... provides a free webinar on Performing Quality Investigations: Getting to Root ... CT at no charge. , Incomplete investigations are still a major concern to ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... the QB3@953 life sciences incubator to accelerate ... The shared laboratory space at QB3@953 was created to ... key obstacle for many early stage organizations - access ... the sponsorship, Amgen launched two "Amgen Golden Ticket" awards, ...
Breaking Biology Technology: